Clinical and molecular survey in 124 Chinese patients with Leigh or Leigh-like syndrome
- PMID: 17323145
- DOI: 10.1007/s10545-006-0481-y
Clinical and molecular survey in 124 Chinese patients with Leigh or Leigh-like syndrome
Abstract
Leigh syndrome is the most common mitochondrial disorder in children characterized by necrotic lesions in the central nervous system. Both mitochondrial DNA (mtDNA) and nuclear DNA defects in the mitochondrial respiratory chain can lead to this disease. To characterize the clinical and genetic traits of Leigh or Leigh-like syndrome patients in China, 124 unrelated cases were collected between 1992 and 2005. Seventy-seven cases (62.1%) met the typical criteria of Leigh syndrome, including symmetrical bilateral abnormal signals in the basal ganglia, thalamus and brain stem, etc. Other cases (37.9%) belonged to Leigh-like syndrome with atypical clinical or radiological manifestations. Late-onset patients accounted for 20.2%, which is more than previously reported. Movement disorder was the most common symptoms in our patients. Thirty-two patients (25.8%) were confirmed to carry mutant genes. Among them, six cases (4.8%) have been demonstrated to have point mutations in mitochondrial DNA. Two separate patients were detected to have mutations on A8344G and A3243G. The T8993G point mutation was identified in one patient and T8993C in one other patient. SURF1 mutations associated with cytochrome-c oxidase deficiency were identified in 25 patients (20.2%). Four unreported variations have been identified in SURF1 gene from three patients. G604C was found in 22 patients. Only one patient had C214T mutation in the pyruvate dehydrogenase E1alpha subunit gene. In the remaining 92 patients (74.2%), a specific molecular dysfunction or underlying metabolic abnormality could not be identified.
Similar articles
-
Clinical and laboratory survey of 65 Chinese patients with Leigh syndrome.Chin Med J (Engl). 2006 Mar 5;119(5):373-7. Chin Med J (Engl). 2006. PMID: 16542579
-
Clinical and magnetic resonance imaging findings in patients with Leigh syndrome and SURF1 mutations.Brain Dev. 2014 Oct;36(9):807-12. doi: 10.1016/j.braindev.2013.10.012. Epub 2013 Nov 18. Brain Dev. 2014. PMID: 24262866
-
[The molecular background of Leigh syndrome].Neurol Neurochir Pol. 2008 May-Jun;42(3):238-50. Neurol Neurochir Pol. 2008. PMID: 18651330 Review. Polish.
-
Mutations in SURF1 are important genetic causes of Leigh syndrome in Slovak patients.Endocr Regul. 2018 Apr 1;52(2):110-118. doi: 10.2478/enr-2018-0013. Endocr Regul. 2018. PMID: 29715184
-
Leigh syndrome: Resolving the clinical and genetic heterogeneity paves the way for treatment options.Mol Genet Metab. 2016 Mar;117(3):300-12. doi: 10.1016/j.ymgme.2015.12.004. Epub 2015 Dec 19. Mol Genet Metab. 2016. PMID: 26725255 Review.
Cited by
-
Clinical exome sequencing reveals a mutation in PDHA1 in Leigh syndrome: A case of a Chinese boy with lethal neuropathy.Mol Genet Genomic Med. 2021 Apr;9(4):e1651. doi: 10.1002/mgg3.1651. Epub 2021 Mar 4. Mol Genet Genomic Med. 2021. PMID: 33661577 Free PMC article.
-
Leigh Syndrome: A Comprehensive Review of the Disease and Present and Future Treatments.Biomedicines. 2025 Mar 17;13(3):733. doi: 10.3390/biomedicines13030733. Biomedicines. 2025. PMID: 40149709 Free PMC article. Review.
-
Mitochondrial dysfunction in epilepsy: mechanistic insights and clinical strategies.Mol Biol Rep. 2025 May 20;52(1):470. doi: 10.1007/s11033-025-10577-1. Mol Biol Rep. 2025. PMID: 40392243 Review.
-
Clinical Diagnosis and Treatment of Leigh Syndrome Based on SURF1: Genotype and Phenotype.Antioxidants (Basel). 2021 Dec 5;10(12):1950. doi: 10.3390/antiox10121950. Antioxidants (Basel). 2021. PMID: 34943053 Free PMC article. Review.
-
Fatal breathing dysfunction in a mouse model of Leigh syndrome.J Clin Invest. 2012 Jul;122(7):2359-68. doi: 10.1172/JCI62923. Epub 2012 Jun 1. J Clin Invest. 2012. PMID: 22653057 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous